Umbilical Cord Mesenchymal Stromal Cells in Serum-Free Defined Medium Display an Improved Safety Profile

Xiaoyun Wu,Zhijie Ma,Yuxiao Yang,Yongxu Mu,Daocheng Wu

DOI: https://doi.org/10.1186/s13287-023-03604-0

2023-01-01

Stem Cell Research & Therapy

Abstract:Background Safety evaluations in preclinical studies are needed to confirm before translating a cell-based product into clinical application. We previously developed a serum-free, xeno-free, and chemically defined media (S&XFM–CD) for the derivation of clinical-grade umbilical cord-derived MSCs (UCMSCs), and demonstrated that intraperitoneal administration of UCMSCs in S&XFM–CD (UCMSC S&XFM−CD ) exhibited better therapeutic effects than UCMSCs in serum-containing media (SCM, UCMSC SCM ). However, a comprehensive investigation of the safety of intraperitoneal UCMSC S&XFM−CD treatment should be performed before clinical applications. Methods In this study, the toxicity, immunogenicity and biodistribution of intraperitoneally transplanted UCMSC S&XFM−CD were compared with UCMSC SCM in rats via general vital signs, blood routine, blood biochemistry, subsets of T cells, serum cytokines, pathology of vital organs, antibody production and the expression of human-specific gene. The tumorigenicity and tumor-promoting effect of UCMSC S&XFM−CD were compared with UCMSC SCM in nude mice. Results We confirmed that intraperitoneally transplanted UCMSC S&XFM−CD or UCMSC SCM did not cause significant changes in body weight, temperature, systolic blood pressure, diastolic blood pressure, heart rate, blood routine, T lymphocyte subsets, and serum cytokines, and had no obvious histopathology change on experimental rats. UCMSC S&XFM−CD did not produce antibodies, while UCMSC SCM had very high chance of antibody production to bovine serum albumin (80%) and apolipoprotein B-100 (60%). Furthermore, intraperitoneally injected UCMSC S&XFM−CD were less likely to be blocked by the lungs and migrated more easily to the kidneys and colon tissue than UCMSC SCM . In addition, UCMSC S&XFM−CD or UCMSC SCM showed no obvious tumorigenic activity. Finally, UCMSC S&XFM−CD extended the time of tumor formation of KM12SM cells, and decreased tumor incidence than that of UCMSC SCM . Conclusions Taken together, our data indicate that UCMSC S&XFM−CD display an improved safety performance and are encouraged to use in future clinical trials.